Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11676
PUT
Enanta Pharmaceuticals
ENTA
$383M
| $68.7K | ﹤0.01% |
1,700
-1,800
| -51% | -$86K |
|
11677
PUT
CapForce IBD 50 ETF
FFTY
$81.2M
| $68.6K | ﹤0.01% |
2,900
+2,600
| +867% | +$59.7K |
|
|
FORA
11678
DELISTED
Forian
FORA
| $68.5K | ﹤0.01% |
17,991
-33,640
| -65% | -$117K |
|
11679
PUT
SELLAS Life Sciences
SLS
$2.58B
| $68.5K | ﹤0.01% |
47,900
+34,200
| +250% | +$84.6K |
|
11680
CALL
SES AI
SES
$223M
| $68.4K | ﹤0.01% |
23,200
-14,700
| -39% | -$46.3K |
|
11681
PUT
Prudential
PUK
$34.7B
| $68.3K | ﹤0.01% |
2,500
+2,100
| +525% | +$63.1K |
|
|
BHR
11682
CALL
Braemar Hotels & Resorts
BHR
$139M
| $68.3K | ﹤0.01% |
17,700
+9,800
| +124% | +$45.7K |
|
11683
PUT
Mirion Technologies
MIR
$3.96B
| $68.3K | ﹤0.01% |
8,000
-12,700
| -61% | -$101K |
|
11684
PUT
Dr. Reddy's Laboratories
RDY
$10.2B
| $68.3K | ﹤0.01% |
6,000
+5,500
| +1,100% | +$59.4K |
|
11685
PUT
Barings BDC
BBDC
$975M
| $68.3K | ﹤0.01% |
8,600
+8,500
| +8,500% | +$71.3K |
|
11686
PUT
Invesco S&P 500 GARP ETF
SPGP
$2.33B
| $68.2K | ﹤0.01% |
+800
| New | +$69.2K |
|
11687
Skillful Craftsman
EDTK
$14M
| $68.2K | ﹤0.01% |
35,719
-702
| -2% | -$1.2K |
|
11688
PUT
Kymera Therapeutics
KYMR
$9.76B
| $68.1K | ﹤0.01% |
2,300
-62,000
| -96% | -$2M |
|
11689
CALL
Westwater Resources
WWR
$72.7M
| $68K | ﹤0.01% |
61,300
-45,400
| -43% | -$47.3K |
|
11690
PUT
iShares MSCI Switzerland ETF
EWL
$2.21B
| $68K | ﹤0.01% |
1,500
-600
| -29% | -$26.5K |
|
11691
PUT
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.7B
| $67.9K | ﹤0.01% |
2,200
+600
| +38% | +$18.2K |
|
|
TURN
11692
DELISTED
180 Degree Capital
TURN
| $67.9K | ﹤0.01% |
13,497
+8,511
| +171% | +$45.2K |
|
11693
PUT
ProShares UltraShort Real Estate
SRS
$15.6M
| $67.9K | ﹤0.01% |
975
-1,100
| -53% | -$74.3K |
|
11694
Ryder
R
$10.1B
| $67.7K | ﹤0.01% |
759
-6,828
| -90% | -$628K |
|
11695
PUT
Schwab US Large- Cap ETF
SCHX
$74.9B
| $67.7K | ﹤0.01% |
4,200
-21,600
| -84% | -$340K |
|
|
SCWX
11696
CALL
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $67.7K | ﹤0.01% |
7,900
+5,500
| +229% | +$42.3K |
|
11697
CALL
Innoviva
INVA
$1.53B
| $67.5K | ﹤0.01% |
6,000
-100
| -2% | -$1.21K |
|
11698
CALL
SKYX Platforms
SKYX
$152M
| $67.5K | ﹤0.01% |
19,500
-12,400
| -39% | -$40.8K |
|
11699
PUT
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$244M
| $67.4K | ﹤0.01% |
+1,800
| New | +$70.4K |
|
|
PINE
11700
PUT
Alpine Income Property Trust
PINE
$348M
| $67.3K | ﹤0.01% |
4,000
+3,700
| +1,233% | +$68.7K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.